A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests accurately detect the protein, ...
Nov 10, 2023
0
69
Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming tumors. The findings, said the researchers, suggest that selectively ...
Jul 6, 2023
0
138
Researchers at Johns Hopkins Medicine say they have created a laboratory-grown three-dimensional "organoid" model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop ...
Dec 1, 2022
0
39
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine. The results suggest ...
Dec 6, 2021
0
46
In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular ...
Jul 23, 2014
0
0
A vast number of microbes colonizes the human body to form an ecological community known as the microbiota. Microbiota are made up of bacteria, viruses, fungi, and archaea. These microbes are closely associated with the physiology ...
Aug 10, 2023
0
1
A new research paper titled "Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer" has been published in Oncotarget.
Feb 14, 2023
0
18
Gastric cancer is a common malignant tumor that originates from the gastric mucosal epithelium. Being insidious and non-specific, the early-stage symptoms of the cancer are similar to that of chronic diseases such as gastritis ...
Sep 28, 2022
0
1
Marital status is likely to be an important contributory factor in predicting long term survival in people with early stage gastric cancer, suggests research published online in the Journal of Investigative Medicine.
Jul 5, 2022
0
11
Initial findings of the phase III KEYNOTE-811 trial of pembrolizumab plus trastuzumab and chemotherapy—first presented at ASCO 2021—have led to the subsequent FDA approval of this combination for the first-line treatment ...
Dec 15, 2021
0
41
